Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

News Daily News

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

Todd Neale

December 08, 2016

News Daily News

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Shelley Wood

September 29, 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

Yael L. Maxwell

August 16, 2016

News Daily News

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

Yael L. Maxwell

August 15, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

Advertisement

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content